ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,963, issued on Aug. 26, was assigned to JAZZ PHARMACEUTICALS RESEARCH UK Ltd. (Sittingbourne, Great Britain).
"Cannabidiol-type cannabinoid compound" was invented by Geoffrey Guy (Cambridge, Great Britain), Volker Knappertz (Cambridge, Great Britain), Benjamin Whalley (Cambridge, Great Britain) and Marie Woolley-Roberts (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, cannabidiol-C1 (CBD-C1), is a naturally occurring cannabinoid that can be found in minor quantities in the cannabis plant. Furthermo...